NORD partners with Medlive to provide accredited online continuing medical education (CME) courses for health care providers. This online platform allows us to reach a large number of learners with accessible, engaging digital courses. We feature top medical specialists from our NORD Rare Disease Centers of Excellence, NORD member advocacy organizations, and rare disease patients themselves. We also offer educational courses designed for patients and caregivers.
NORD and Medlive are proud to feature ongoing courses about rare cancers as an important part of our CME offerings. These courses are available for credit for one year following their publication. Check out some of the past CME sessions on rare oncological conditions below.
The following sessions can be viewed, but are no longer available for CME credit and the content is current as of the published date below:
“Improving Quality of Life with Treatment Approaches in Graft versus Host Disease” (published 6/9/2022)
AL Amyloidosis: “A Rare Blood Disorder with Multi-Organ Complications” (published 4/20/2022)
Waldenström’s Macroglobulinemia: “Systemic Therapy for Symptomatic Patients with Waldenström’s Macroglobulinemia” (published 6/1/2022)
Paroxysmal Nocturnal Hemoglobinuria (PNH): “New Treatment Options for the Paroxysmal Nocturnal Hemoglobinuria (PNH) Community” (published 4/29/2022)
Cold Agglutinin Disease (CAD): “Impact of a Rare Anemia and the Promise of New Therapies” (published 4/29/2022)
T-Cell Lymphomas: “CD30‐Targeted Treatment Approaches for Patients with PTCL and CTCL” (published 8/17/2022)
Explore all of NORD’s rare disease CME content and sign up for updates here.
